Analytical Data
-
基因名
SATB2
- Application
-
别名
DNA-binding protein SATB2; Special AT-rich sequence-binding protein 2
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UPW6
-
表达区间
Lys350~His672
-
分子量
44kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SATB2 (Special AT-rich Sequence-Binding Protein 2) is a transcription factor that plays a crucial role in craniofacial development, neuronal function, and the regulation of gene expression. Mutations or deletions in the SATB2 gene are linked to a range of developmental disorders, including intellectual disabilities and specific craniofacial abnormalities. Recent research has highlighted the importance of SATB2 in various biological processes, such as cell differentiation and the maintenance of pluripotency in stem cells. Understanding the structure and function of SATB2 is vital for elucidating its role in these developmental pathways. The recombination and production of SATB2 proteins, often through methods like recombinant DNA technology, enable further analysis of its functional domains, interaction with other proteins, and regulatory mechanisms. This research could ultimately lead to therapeutic strategies for conditions associated with SATB2 dysfunction, enhancing our understanding of both normal development and disease pathology.
